Clinical Trial

Valbenazine in Obsessive Compulsive Disorder

Name: Valbenazine in Obsessive Compulsive Disorder — clinical trial record (NCT07111988)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The primary aim of the study is to examine the efficacy and safety of valbenazine in adults with moderate to severe obsessive-compulsive disorder (OCD).

Protocol Amendment History 7 amendments

This ClinicalTrials.gov record has been amended 7 times since 2025-08-01; most recent amendment 2026-06-08.

Trial Details

NCT Number	NCT07111988
Lead Sponsor	University of Chicago Collaborators: Neurocrine Biosciences
Conditions	Obsessive-Compulsive Disorder
Enrollment	30 participants
Start Date	2026-06
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-10